Neith

Neith CapEx/D&A

CapEx to Depreciation Ratio of Neith (6236.TWO) as of Nov 19, 2026.

CapEx/D&A

-

Last updated:

CapEx to Depreciation Ratio of Neith is 2026 - . CapEx to Depreciation Ratio of Neith was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neith Stock analysis

What does Neith do? Neith Corp generates revenue through two distinct business segments: biomedical and semiconductor. The biomedical segment focuses on the manufacture and sales of rock baths, peripheral products, and negative ion products, alongside the provision of preventive medical services including genetic testing and consulting. Additionally, the firm engages in the rental of medical instruments to support its healthcare offerings. The semiconductor segment is primarily dedicated to the development of integrated circuit products, such as microcontrollers and their peripheral products. These products are mainly targeted at domestic sales. Neith is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neith stock

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Neith since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Neith with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Neith

All Key Metrics — Neith